Gene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug development

scientific article published on 12 November 2010

Gene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug development is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JBT.20375
P698PubMed publication ID21671310
P5875ResearchGate publication ID51217381

P50authorJean-Marc PlancherQ107363976
P2093author name stringFranziska Boess
Guido Steiner
Laura Suter
Susanne Raab
Adrian Roth
Thomas Weiser
Christian Freichel
Christian Landes
Cristina de Vera Mudry
P2860cites workEnhanced expression of rat hepatic microsomal epoxide hydrolase by methylthiazole in conjunction with liver injury.Q53409740
cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3Q22010180
Cluster analysis and display of genome-wide expression patternsQ24644463
GoMiner: a resource for biological interpretation of genomic and proteomic dataQ24796534
Discriminating different classes of toxicants by transcript profilingQ24813403
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2Q27642888
p53-independent induction of rat hepatic Mdm2 following administration of phenobarbital and pregnenolone 16alpha-carbonitrile.Q27863459
GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent mannerQ28294595
Paraquat-generated oxidative stress in rat liver induces heme oxygenase-1 and aminolevulinic acid synthaseQ28572039
Workgroup report: Review of genomics data based on experience with mock submissions--view of the CDER Pharmacology Toxicology Nonclinical Pharmacogenomics SubcommitteeQ33238356
Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survivalQ34567790
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the hostQ35753611
Key factors in the rising cost of new drug discovery and developmentQ35770173
Assessment of hepatotoxic liabilities by transcript profilingQ36180136
Toxicogenomic analysis methods for predictive toxicologyQ36291208
Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix databaseQ36629988
De novo cholesterol synthesis at the crossroads of adaptive response to extracellular stress through SREBP.Q36632466
Review article: drug hepatotoxicityQ36798653
LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidneyQ36870559
Safety evaluation to support First-In-Man investigations II: toxicology studiesQ37172313
Commentary: regulatory toxicology and the critical path: predicting long-term outcomes from short-term studiesQ37251498
Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanismQ38308355
Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout miceQ39946599
Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicityQ40113098
A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening systemQ40519669
A Link between cholesterol levels and phenobarbital induction of cytochromes P450.Q43887283
Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrateQ44506981
Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesionsQ44615152
Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approachQ44650830
Phenobarbital treatment enhances insulin-mediated glucose metabolism and improves lipid metabolism in the diabetic rat.Q45952388
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.Q46004264
Toxicogenomic analysis of gene expression changes in rat liver after a 28-day oral benzene exposureQ46476989
Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats.Q46564782
Gene expression profiling of methapyrilene-induced hepatotoxicity in rat.Q46731451
Tailored gene array databases: applications in mechanistic toxicologyQ48557203
TNF-alpha interferes with lipid homeostasis and activates acute and proatherogenic processes.Q51469597
P433issue3
P304page(s)183-194
P577publication date2010-11-12
P1433published inJournal of Biochemical and Molecular ToxicologyQ15724515
P1476titleGene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug development
P478volume25

Reverse relations

cites work (P2860)
Q38025961A decade of toxicogenomic research and its contribution to toxicological science
Q30572803Comparison of genotoxicant-modified transcriptomic responses in conventional and epigenetically stabilized primary rat hepatocytes with in vivo rat liver data
Q42719237Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver
Q26821951Decoding mechanisms by which silent codon changes influence protein biogenesis and function
Q28730554Predictive modeling of chemical hazard by integrating numerical descriptors of chemical structures and short-term toxicity assay data
Q40843389Release of (and lessons learned from mining) a pioneering large toxicogenomics database.

Search more.